MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company’s lead program is THIO, a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of telomerase-positive cancer cells.

Address: 444 West Lake Street,Suite 1700 Chicago IL 60606 US
Phone: +1 312 416-8592

In The Press

MAIA Biotechnology Inc. News